NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 25, 2025 — Governor Newsom appoints Dr. Steve Manyak to California Veterinary Medical Board. The Pine Animal Hospital veterinarian will help regulate veterinary practices and standards statewide.
September 24, 2025 — Adageis launches AI platform to simplify healthcare's transition to value-based care. The patented technology provides contract visibility and financial monitoring for providers seeking operational efficiency.
September 24, 2025 — Stonegate Capital Partners initiates coverage on Medicus Pharma, highlighting strategic acquisitions, thermostable vaccine development, and innovative microneedle technology for skin cancer treatment with $21.13 valuation midpoint.
September 24, 2025 — Calay Ip, new COO of Element Care PACE, discusses senior care innovation, PACE model expansion, and technology-driven solutions for aging population needs and value-based care transformation.
September 24, 2025 — TSC Life receives FDA clearance for Fluido AirGuard System, a high-flow blood and fluid warmer with automatic air detection to prevent hypothermia during medical procedures.
September 24, 2025 — Soligenix advances HyBryte™ for cutaneous T-cell lymphoma with positive FLASH trial results. Learn about the breakthrough treatment and ongoing FLASH 2 study milestones.
September 24, 2025 — Strawberry Fields REIT CEO Moishe Gubin discusses company's 10-year success, 11% annual growth, and healthcare property portfolio on Bell2Bell Podcast. Learn about STRW's investment strategy.
September 24, 2025 — Fulbright Canada partners with Memores Software to combat campus mental health crisis using AI-driven emotional targeting technology and research collaboration.
September 24, 2025 — Lionheart Health presents regenerative longevity technology at Octane Medical Innovation Forum. Learn about their bioelectric signaling platform for organ regeneration and healthspan extension.
September 24, 2025 — Oncotelic Therapeutics receives Australian ethics approval for Phase 1 trial of injectable Everolimus for breast cancer using innovative Deciparticle technology for improved drug absorption.
September 24, 2025 — GeoVax expands Gedeptin cancer therapy to multiple solid tumors including breast cancer. Novel gene-directed enzyme prodrug therapy combines with checkpoint inhibitors for enhanced treatment outcomes.
September 24, 2025 — Stanford's Dr. Fatima Rodriguez receives 2025 Joseph A. Vita Award for transformative cardiovascular research advancing personalized prevention strategies and health equity.
September 24, 2025 — Maryland health officials issue independent vaccine recommendations as state faces political pressure, economic relief measures, and preservation battles affecting residents' health and livelihoods.
September 24, 2025 — AICU Global launches Fecal Scanner AI app via Indiegogo campaign. Revolutionary gut health monitoring using photo analysis and AI technology for IBD/IBS patients.
September 24, 2025 — Scott H. Silverman releases "You're Not God That Job Is Taken," a guide for families facing addiction. Offers hope, tools for recovery, and support for veterans and professionals.
September 24, 2025 — CCHR's Psychiatry: An Industry of Death exhibit at UCF exposes mental health abuses, featuring Commissioner Tony Ortiz. Learn about Baker Act concerns and parental rights resources.
September 24, 2025 — New research shows couples with strong listening skills are 43x more likely to have thriving relationships. Oliver Drakeford Therapy reveals data from 1,300+ couples.
September 23, 2025 — Izotropic integrates personalized radiation dosing into breast CT system using UC Davis models. First breast CT with real-time customized dosing advances through FDA approval for global market.
September 23, 2025 — NextPlat's ClearMetrx subsidiary develops AI-powered healthcare analytics platform with revenue forecasting and fraud prevention capabilities for 2026 launch.
September 23, 2025 — Soligenix appoints Dr. Tomas J. Philipson, ex-White House advisor, to advance HyBryte™ for rare diseases. Learn how this boosts their pipeline and regulatory strategy.